BridgeBio Inc. seeks a Skeletal Dysplasia Account Manager to drive the launch of Infigratinib, a first-in-class therapy for achondroplasia.
This high-impact role partners with providers and families, combining clinical acumen with urgency and a passion for education. Based in the West Region with territories spanning San Diego, LA, San Jose, Seattle, Omaha, Denver, San Francisco, the role requires travel and cross-functional collaboration with Field Medical Directors, Marketing, and Medical
#J-18808-LjbffrRemote Skeletal Dysplasia Account Lead in san jose at Unknown Company
This position is listed as full time and onsite.